Cisplatin (Cis-DDP) is one of the most widely used anti-cancer drugs. It is applicable to many types of cancer, including lung, bladder, and breast cancer. However, its use is now limited because of drug resistance. p90 ribosomal S6 kinase (p90RSK) is one of the downstream effectors in the extracellular signalregulated protein kinases 1 and 2 (ERK1/2) pathway and high expression of p90RSK is observed in human breast cancer tissues. Therefore, we investigated the role of p90RSK in the Cis-DDP resistance-related signaling pathway and epithelialmesenchymal transition (EMT) in breast cancer cells. First, we discovered that MDA-MB-231 cells exhibited more Cis-DDP resistance than other breast cancer cells, including MCF-7 and BT549 cells. Cis-DDP increased p90RSK activation, whereas the inactivation of p90RSK using a small interfering RNA (siRNA) or dominant-negative kinase mutant plasmid overexpression significantly reduced Cis-DDP-induced cell proliferation and migration via the inhibition of matrix metallopeptidase (MMP)2 and MMP9 in MDA-MB-231 cells. In addition, p90RSK activation was involved in EMT via the upregulation of mRNA expression, including that of Snail, Twist, ZEB1, N-cadherin, and vimentin. We also investigated NF-κB, the upstream regulator of EMT markers, and discovered that Cis-DDP treatment led to NF-κB translocation in the nucleus as well as its promoter activity. Our results suggest that targeting p90RSK would be a good strategy to increase Cis-DDP sensitivity in triple-negative breast cancers. [BMB Reports 2019; 52(12): 706-711].
Conflict of interest statement
The authors have no conflicting interests.
Long Non-Coding RNA H19 Mediates Ovarian Cancer Cell Cisplatin-Resistance and Migration During EMTY Wu et al. Int J Clin Exp Pathol 12 (7), 2506-2515. PMID 31934077.LncRNA H19 is responsible for the cisplatin-resistance, migration, and MET regulation in OVCAR3 cells.
miR-206 Regulates Cisplatin Resistance and EMT in Human Lung Adenocarcinoma Cells Partly by Targeting METQY Chen et al. Oncotarget 7 (17), 24510-26. PMID 27014910.MicroRNAs (miRNAs) play a critical role in drug resistance and epithelial-mesenchymal transition (EMT). The aims of this study were to explore the potential role of miR-2 …
Enterolactone Modulates the ERK/NF-κB/Snail Signaling Pathway in Triple-Negative Breast Cancer Cell Line MDA-MB-231 to Revert the TGF-β-induced Epithelial-Mesenchymal TransitionAV Mali et al. Cancer Biol Med 15 (2), 137-156. PMID 29951338.Briefly, EL was found to inhibit TGF-β-induced EMT by blocking the ERK/NF-κB/Snail signaling pathway, which is a promising target for breast cancer metastasis therapy. …
Cathepsin L Upregulation-Induced EMT Phenotype Is Associated With the Acquisition of Cisplatin or Paclitaxel Resistance in A549 CellsML Han et al. Acta Pharmacol Sin 37 (12), 1606-1622. PMID 27840408.Cisplatin and paclitaxel resistance is associated with CTSL upregulation-induced EMT in A549 cells. Thus, CTSL-mediated EMT may be exploited as a target to enhance the ef …
Inhibition of p90 Ribosomal S6 Kinase Attenuates Cell Migration and Proliferation of the Human Lung Adenocarcinoma Through phospho-GSK-3β and OsteopontinN Abdulrahman et al. Mol Cell Biochem 418 (1-2), 21-9. PMID 27236820.p90 ribosomal S6 kinase (p90RSK) constitutes a family of serine/threonine kinases that have been shown to be involved in cell proliferation of various malignancies via di …